ArticleBMC urology2025
Correlation between total prostate specific antigen and histological grading of prostate cancer in Kenyan mission hospital: a five-year retrospective review.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundProstate cancer (CaP) is the leading non-cutaneous cancer in men of African descent, with the higher mortality rates found in sub-Saharan Africa. Early diagnosis, staging, and management of prostate cancer could help curb its mortality rate in SSA. However, access to precise radiological imaging for staging purposes is limited in our setting. We sought to evaluate the correlation between total prostate specific antigen (tPSA) and histological grading of CaP in our resource-limited setting.
methodWe conducted a retrospective review of records of patients treated for biopsy-proven CaP at the AICKH diagnosed between January 2018 and December 2022. We excluded patients who were already on any sort of treatment of bladder outlet obstruction and incomplete charts. We used Spearman correlation coefficients, and ANOVA to evaluate the relationship between tPSA and various grading parameters. A P-value less than 0.05 was considered significant.
resultsWe included 327 medical records. The mean tPSA was 112 ± 4.5ng/ml. The most common Gleason score and grade group were 8 (33.8%) and 4 (33.8%) respectively. Perineural involvement was present in 33% of our population. The tPSA had a positive correlation with Gleason score (rho = 0.253, p < 0.001), grade group (rho = 0.296, p < 0.001), perineural involvement (rho = 0.241, p = 0.001) and proportion of sample invasion (rho = 0.171, p = 0.005). A linear and homogenous variance existed in mean tPSA across increasing Gleason score (p < 0.001).
conclusiontPSA is a good predictor of the severity of CaP in resource-limited settings and can be used to inform management decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.